Japan· JP-4300450G1027
イブリツモマブ チウキセタン(遺伝子組換え)・塩化インジウム(111In)
A medicinal product containing イブリツモマブ チウキセタン(遺伝子組換え)・塩化インジウム(111in), registered in Japan by ムンディファーマ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- イブリツモマブ チウキセタン(遺伝子組換え)・塩化インジウム(111In)
- Manufacturer
- ムンディファーマ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
イブリツモマブ チウキセタン(遺伝子組換え)・塩化インジウム(111in) in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumZevalin 1.6 mg/mlCeft Biopharma
- SpainZEVALIN 1,6 mg/ml, EQUIPO REACTIVO PARA LA PREPARACION DE UN RADIOFARMACO PARA PERFUSIONCeft Biopharma S.R.O.
- FinlandZevalinCeft Biopharma s.r.o.
- United KingdomZevalin 3.2mg/2ml kit for radiopharmaceutical preparationCurium Pharma UK Ltd
- IrelandZevalinCeft Biopharma s.r.o
- PolandZevalinCeft Biopharma s.r.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd59e8ed-5e5f-4a4a-81f4-732dd75d18ab GET /v1/drugs/dd59e8ed-5e5f-4a4a-81f4-732dd75d18ab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "1セット",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "4300450G1027",
"category": "注射薬",
"price_yen": 1872027,
"generic_name": "イブリツモマブ チウキセタン(遺伝子組換え)・塩化インジウム(111In)",
"product_name_jp": null,
"therapeutic_class": "4300",
"transitional_expiry": null
}See everything about イブリツモマブ チウキセタン(遺伝子組換え)・塩化インジウム(111in).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.